Heart Disease Clinical Trials in Baltimore

Showing 461-480 of 583 trials

Video-Assisted Left Atrial Appendage Exclusion Trial

NCT02226133

Exclusion of the LAA(Left Atrial Appendage) using the TigerPaw II System with VATS technique is safe and effective.

LAAx, Inc.Started Apr 2015

Pleasanton, California, United States • Baltimore, Maryland, United States • Danville, Pennsylvania, United States +1 more locations

UNKNOWNPhase 2/3< 1 mile

BioFreedom US IDE Feasibility Trial

NCT02131142

The purpose of this study is to collect additional safety and effectiveness data for on the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in patients with native, de novo coronary artery disease.

Ischemic Heart DiseaseStable AnginaUnstable Angina+1 more

Biosensors Europe SA72 participantsStarted Aug 2014

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Atlanta, Georgia, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

NCT00094302

The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.

Cardiovascular DiseasesHeart DiseasesHeart Failure, Congestive

Carelon Research3,445 participantsStarted Aug 2006

Birmingham, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +267 more locations

Video-Assisted Left Atrial Appendage Exclusion Trial

BioFreedom US IDE Feasibility Trial

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

Heart Disease Trials in Other Cities

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

The OMEGA Clinical Trial

A Pharmacodynamic Study With Ticagrelor in African American Patients

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL

TAXUS Libertē Post Approval Study

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

SHORTness of Breath In the Emergency Department (SHORTIE)

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

Radial Artery Access With Ultrasound Trial

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea

Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure

Other Conditions in Baltimore